NCT04439279
Clinical Trial Information
Trial Number: NCT04439279 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Miscellaneous
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol R: Phase II Study of Trametinib in Patients With BRAF Fusions, or With NonV600E, Non-V600K BRAF Mutations
Study ID:
EAY131-R
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®